The DOI matches its Crossref record; 191 of the 193 references it cites were found in a registry or an index.
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Open accessAbstract
The incidence and prevalence of diabetes mellitus have grown significantly throughout the world, due primarily to the increase in type 2 diabetes. This overall increase in the number of people with diabetes has had a major impact on development of diabetic kidney disease (DKD), one of the most frequent complications of both types of diabetes. DKD is the leading cause of end-stage renal disease (ESRD), accounting for approximately 50% of cases in the developed world. Although incidence rates for ESRD attributable to DKD have recently stabilized, these rates continue to rise in high-risk groups such as middle-aged African Americans, Native Americans, and Hispanics. The costs of care for people with DKD are extraordinarily high. In the Medicare population alone, DKD-related expenditures among this mostly older group were nearly $25 billion in 2011. Due to the high human and societal costs, the Consensus Conference on Chronic Kidney Disease and Diabetes was convened by the American Diabetes Association in collaboration with the American Society of Nephrology and the National Kidney Foundation to appraise issues regarding patient management, highlighting current practices and new directions. Major topic areas in DKD included 1) identification and monitoring, 2) cardiovascular disease and management of dyslipidemia, 3) hypertension and use of renin-angiotensin-aldosterone system blockade and mineralocorticoid receptor blockade, 4) glycemia measurement, hypoglycemia, and drug therapies, 5) nutrition and general care in advanced-stage chronic kidney disease, 6) children and adolescents, and 7) multidisciplinary approaches and medical home models for health care delivery. This current state summary and research recommendations are designed to guide advances in care and the generation of new knowledge that will meaningfully improve life for people with DKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A1C levels are also less reliable at advanced CKD stages (64,65).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [64]
The cited source says what the claim attributes to it.
In the citing paper
“A1C levels are also less reliable at advanced CKD stages (63,64).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [63]
In the citing paper
“There is no evidence that adjusting the daily level of protein intake (typically 1-1.5 g/kg body wt/day or 15-20% total calories) will improve health, and research is inconclusive regarding the ideal amount of dietary protein to optimize either glycemic management or CVD risk (159,195).”
From 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes:Standards of Care in Diabetes—2023 (2023) · cites this paper as [195]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedAhmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
Standards of Medical Care in Diabetes
Power, D. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,676
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Self-citationBrenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Adherence to Long-Term Therapies: Evidence for Action
Geest, S. D., & Sabate, E. J. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00091-4 · Cited by 6,310
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Adherence to Long‐Term Therapies: Evidence for Action
Burkhart, P. V., & Sabaté, E. (2003) · Journal of Nursing Scholarship · doi:10.1111/j.1547-5069.2003.tb00001.x · Cited by 2,526
Andrássy, K. (2013) · Kidney International · doi:10.1038/ki.2013.243 · Cited by 2,495
Economic Costs of Diabetes in the U.S. in 2012
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc12-2625 · Cited by 2,227
A Controlled Trial of Renal Denervation for Resistant Hypertension
Bhatt, D. L., Kandzari, D. E., O'Neill, W. W., D'Agostino, R., Flack, J. M., Katzen, B. T., Leon, M. B., Liu, M., Mauri, L., Negoita, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402670 · Cited by 2,186
Self-citation(2000) · PubMed · Cited by 2,095
Translating the A1C assay into estimated average glucose values
Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & for the A1c-Derived Average Glucose (ADAG) Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0545 · Cited by 1,812
Adler, A., Stevens, R., Manley, S. E., Bilous, R., Cull, C. A., Holman, R. R., & UKPDS Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00712.x · Cited by 1,800
Self-citation(2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.12.005 · Cited by 1,788
Mann, J. F. E., Schmieder, R. E., McQueen, M., Dyal, L., Schumacher, H., Pogue, J. M., Wang, X., Maggioni, A. P., Budaj, A., Chaithiraphan, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61236-2 · Cited by 1,579
Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60576-4 · Cited by 1,428
Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009
Dabelea, D., Mayer-Davis, E. J., Saydah, S., Imperatore, G., Linder, B., Divers, J., Bell, R., Badaru, A., Talton, J. W., Crume, T., et al. (2014) · JAMA · doi:10.1001/jama.2014.3201 · Cited by 1,412
Fox, C. S., Matsushita, K., Woodward, M., Bilo, H. J., Chalmers, J., Heerspink, H. J. L., Lee, B. J., Perkins, R. M., Rossing, P., Sairenchi, T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61350-6 · Cited by 1,401
Cherney, D. Z. I., Perkins, B. A., Soleymanlou, N., Maione, M., Lai, V., Lee, A., Fagan, N. M., Woerle, H. J., Johansen, O. E., Broedl, U. C., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005081 · Cited by 1,329
KDOQI clinical practice guideline for diabetes and CKD: 2012 update
(2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.07.005 · Cited by 1,320
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
Parving, H.-H., Brenner, B. M., McMurray, J. J. V., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Persson, F., Desai, A. S., Nicolaides, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208799 · Cited by 1,319
Ali, S., Stone, M. A., Peters, J., Davies, M. J., & Khunti, K. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01943.x · Cited by 1,311
Kidney disease and increased mortality risk in type 2 diabetes
Afkarian, M., Sachs, M. C., Kestenbaum, B., Hirsch, I. B., Tuttle, K. R., Himmelfarb, J., & de Boer, I. H. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012070718 · Cited by 1,298
Self-citationReverse epidemiology of cardiovascular risk factors in maintenance dialysis patients
Kalantar‐Zadeh, K., Block, G., Humphreys, M. H., & Kopple, J. D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00803.x · Cited by 1,252
Self-citationPredictors of New-Onset Kidney Disease in a Community-Based Population
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.291.7.844 · Cited by 1,241
Zatz, R., Dunn, B. R., Meyer, T. W., Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112521 · Cited by 1,204
Combined angiotensin inhibition for the treatment of diabetic nephropathy
Fried, L. F., Emanuele, N., Zhang, J. H., Brophy, M., Conner, T. A., Duckworth, W., Leehey, D. J., McCullough, P. A., O'Connor, T., Palevsky, P. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303154 · Cited by 1,169
Nutrition therapy recommendations for the management of adults with diabetes
Evert, A. B., Boucher, J. L., Cypress, M., Dunbar, S. A., Franz, M. J., Mayer-Davis, E. J., Neumiller, J. J., Nwankwo, R., Verdi, C. L., Urbanski, P., et al. (2013) · Diabetes Care · doi:10.2337/dc13-2042 · Cited by 1,129
Self-citationHypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus
Whitmer, R. A. (2009) · JAMA · doi:10.1001/jama.2009.460 · Cited by 1,128
Renders, C. M., Valk, G. D., Griffin, S. J., Wagner, E. H., Eijk van, J. T., & Assendelft, W. J. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.10.1821 · Cited by 1,066
Temporal trends in the prevalence of diabetic kidney disease in the United States
de Boer, I. H. (2011) · JAMA · doi:10.1001/jama.2011.861 · Cited by 1,036
Palmer, S., Vecchio, M., Craig, J. C., Tonelli, M., Johnson, D. W., Nicolucci, A., Pellegrini, F., Saglimbene, V., Logroscino, G., Fishbane, S., et al. (2013) · Kidney International · doi:10.1038/ki.2013.77 · Cited by 925
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter (posthumous), E. E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002967.pub4 · Cited by 893
Regression of Microalbuminuria in Type 1 Diabetes
Perkins, B. A., Ficociello, L., Silva, K. H., Finkelstein, D. M., Warram, J. H., & Królewski, A. S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021835 · Cited by 799
Messerli, F. H., Mancia, G., Conti, C. R., Hewkin, A. C., Kupfer, S., Champion, A., Kolloch, R. E., Bénétos, A., & Pepine, C. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-12-200606200-00005 · Cited by 777
Nutrition therapy recommendations for the management of adults with diabetes
Evert, A. B., Boucher, J. L., Cypress, M., Dunbar, S. A., Franz, M. J., Mayer-Davis, E. J., Neumiller, J. J., Nwankwo, R., Verdi, C. L., Urbanski, P., et al. (2014) · Diabetes Care · doi:10.2337/dc14-s120 · Cited by 766
Self-citationTonelli, M. A., Muntner, P., Lloyd, A. M., Manns, B., Klarenbach, S. W., Pannu, N., James, M. T., & Hemmelgarn, B. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60572-8 · Cited by 733
Tyson, C. C., & Coffman, T. M. (2017) · The Nephron journals/Nephron journals · doi:10.1159/000455130 · Cited by 715
Association between obesity and kidney disease: A systematic review and meta-analysis
Wang, Y., Chen, X., Song, Y., Caballero, B. H., & Cheskin, L. J. (2007) · Kidney International · doi:10.1038/sj.ki.5002586 · Cited by 693
Kohan, D. E., Fioretto, P., Tang, W., & List, J. F. (2014) · Kidney International · doi:10.1038/ki.2013.356 · Cited by 652
Wanner, C., the Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members, & Tonelli, M. (2014) · Kidney International · doi:10.1038/ki.2014.31 · Cited by 649 · cited 2×
“Thus, as recommended by the recently released KDIGO guidelines, statins are recommended for all diabetic patients with nondialysis-dependent CKD (34).”
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes
Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., et al. (2009) · Diabetes · doi:10.2337/db08-1543 · Cited by 638
Gerich, J. E., Meyer, C., Woerle, H. J., & Stümvoll, M. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.382 · Cited by 602
The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus
Borch‐Johnsen, K., Andersen, P. K., & Deckert, T. (1985) · Diabetologia · doi:10.1007/bf00281993 · Cited by 601
Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension
Bisognano, J. D., Bakris, G., Nadim, M. K., Sanchez, L., Kroon, A. A., Schafer, J., de Leeuw, P. W., & Sica, D. A. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.008 · Cited by 600
Self-citationMajor Dietary Protein Sources and Risk of Coronary Heart Disease in Women
Bernstein, A. M., Sun, Q., Hu, F. B., Stampfer, M. J., Manson, J. E., & Willett, W. C. (2010) · Circulation · doi:10.1161/circulationaha.109.915165 · Cited by 573
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.46 · Cited by 522
Pedrini, M. T., Levey, A. S., Lau, J., Chalmers*, T. C., & Wang, P. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-7-199604010-00002 · Cited by 496
Inaba, M., Okuno, S., Kumeda, Y., Yamada, S., Imanishi, Y., Tabata, T., Okamura, M., Okada, S., Yamakawa, T., Ishimura, E., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070772 · Cited by 495
Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH)
Sacks, F. M., Obarzanek, E., WINDHAUSER, M. M., Svetkey, L. P., Vollmer, W. M., McCullough, M. L., KARANJA, N. M., Lin, P., Steele, P., Proschan, M. A., et al. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(94)00055-x · Cited by 490
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
Yale, J., Bakris, G. L., Cariou, B., Yue, D. K., David‐Neto, E., Xi, L., Figueroa, K., Wajs, E., Usiskin, K., & Meininger, G. E. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12090 · Cited by 485
Self-citationRisk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter, E. E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002967.pub3 · Cited by 447
Hypoglycemia in Type 2 Diabetes
Zammitt, N. N., & Frier, B. M. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2948 · Cited by 435
Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency
Lipska, K. J., Bailey, C. J., & Inzucchi, S. E. (2011) · Diabetes Care · doi:10.2337/dc10-2361 · Cited by 432
Miller, M. E., Bonds, D. E., Gerstein, H. C., Seaquist, E. R., Bergenstal, R. M., Calles-Escandon, J., Childress, R. D., Craven, T. E., Cuddihy, R. M., Dailey, G., et al. (2010) · BMJ · doi:10.1136/bmj.b5444 · Cited by 429
Prevalence of Diabetes in U.S. Youth in 2009: The SEARCH for Diabetes in Youth Study
Pettitt, D. J., Talton, J. W., Dabelea, D., Divers, J., Imperatore, G., Lawrence, J. M., Liese, A. D., Linder, B. L., Mayer‐Davis, E. J., Pihoker, C., et al. (2013) · Diabetes Care · doi:10.2337/dc13-1838 · Cited by 428
Knight, E. L., Stampfer, M. J., Hankinson, S. E., Spiegelman, D., & Curhan, G. C. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-6-200303180-00009 · Cited by 426
Nonalbuminuric Renal Insufficiency in Type 2 Diabetes
MacIsaac, R. J., Tsalamandris, C., Panagiotopoulos, S., Smith, T. J., McNeil, K. J., & Jerums, G. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.195 · Cited by 410
Kasiske, B., Lakatua, J., Ma, J., & Louis, T. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9631839 · Cited by 408
Kim, Y. G., Hahn, S., Oh, T. J., Kwak, S. H., Park, K. S., & Cho, Y. (2013) · Diabetologia · doi:10.1007/s00125-012-2827-3 · Cited by 396
Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials
Ismail‐Beigi, F., Moghissi, E. S., Tiktin, M., Hirsch, I. B., Inzucchi, S. E., & GENUTH, S. M. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-8-201104190-00007 · Cited by 388
Self-citationMehdi, U. F., Adams-Huet, B., Raskin, P., Vega, G. L., & Toto, R. D. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070737 · Cited by 388
Antihypertensive Therapy in the Presence of Proteinuria
Sarafidis, P. A., Khosla, N., & Bakris, G. L. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.10.014 · Cited by 378
Self-citationHoltkamp, F. A., de Zeeuw, D., Thomas, M. C., Cooper, M. E., de Graeff, P. A., Hillege, H. J. L., Parving, H.-H., Brenner, B. M., Shahinfar, S., & Lambers Heerspink, H. J. (2011) · Kidney International · doi:10.1038/ki.2011.79 · Cited by 364
Palmer, S. C., Craig, J. C., Navaneethan, S. D., Tonelli, M., Pellegrini, F., & Strippoli, G. F. M. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-4-201208210-00007 · Cited by 359
Self-citationMagee, G., Bilous, R., Cardwell, C., Hunter, S., Kee, F., & Fogarty, D. (2009) · Diabetologia · doi:10.1007/s00125-009-1268-0 · Cited by 349
Self-citationCore Principles & Values of Effective Team-Based Health Care
University of Washington, Mitchell, P. H., Wynia, M. K., American Medical Association, Golden, R., Rush University Medical Center, McNellis, B., American Academy of Physician Assistants, Okun, S., PatientsLikeMe, et al. (2012) · NAM Perspectives · doi:10.31478/201210c · Cited by 349
Holdaas, H., Fellström, B., Cole, E., Nyberg, G., OLSSON, A. G., Pedersen, T. R., Madsen, S., Grönhagen‐Riska, C., Neumayer, H. ‐., Maes, B., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01105.x · Cited by 346
Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy
Hansen, H. P., Tauber-Lassen, E., Jensen, B. R., & Parving, H. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00421.x · Cited by 331
Qaseem, A., Humphrey, L. L., Fitterman, N., Starkey, M., & Shekelle, P. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-11-201312030-00009 · Cited by 329
Randomised controlled trial of structured personal care of type 2 diabetes mellitus
Olivarius, N. D. F., Beck-Nielsen, H., Andreasen, A., Hørder, M., & Pedersen, P. A. (2001) · British medical journal · doi:10.1136/bmj.323.7319.970 · Cited by 323
Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies
Morales, E., Valero, M. A., León, M., Hernández, E., & Praga, M. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50039 · Cited by 320
The association among smoking, heavy drinking, and chronic kidney disease.
Shankar, A., Klein, R., & Klein, B. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj173 · Cited by 287
Rapid Rise in Hypertension and Nephropathy in Youth With Type 2 Diabetes
TODAY Study Group (2013) · Diabetes Care · doi:10.2337/dc12-2420 · Cited by 285
Pogue, V. A., Rahman, M., Lipkowitz, M. S., Toto, R. D., Miller, E. R., Faulkner, M. L., Rostand, S. G., Hiremath, L., Sika, M., Kendrick, C. A., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.115154 · Cited by 282
Shurraw, S. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.537 · Cited by 270
Holstein, A., Plaschke, A., & Egberts, E. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.235 · Cited by 264
The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease
Odermatt, A. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00068.2011 · Cited by 262
A1C and Survival in Maintenance Hemodialysis Patients
Kalantar‐Zadeh, K., Kopple, J. D., Regidor, D. L., Jing, J., Shinaberger, C. S., Aronovitz, J., McAllister, C. J., Whellan, D. J., & Sharma, K. (2007) · Diabetes Care · doi:10.2337/dc06-2127 · Cited by 258
Self-citationEfficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review
Aroda, V. R., Henry, R. R., Han, J., Huang, W., DeYoung, M. B., Darsow, T., & Hoogwerf, B. J. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.04.013 · Cited by 253
Kohan, D. E., Pritchett, Y., Molitch, M. E., Wen, S., Garimella, T. S., Audhya, P., & Andress, D. L. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080869 · Cited by 241
Self-citationPitt, B., Bakris, G. L., Ruilope, L. M., DiCarlo, L. A., & Mukherjee, R. (2008) · Circulation · doi:10.1161/circulationaha.108.778811 · Cited by 237
Self-citationProtein restriction for diabetic renal disease
Robertson, L. M., Waugh, N., & Robertson, A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002181.pub2 · Cited by 234
He, F., Xia, X., Wu, X. F., Yu, X. Q., & Huang, F. X. (2013) · Diabetologia · doi:10.1007/s00125-012-2796-6 · Cited by 228
Reverse Epidemiology of Hypertension and Cardiovascular Death in the Hemodialysis Population
Kalantar‐Zadeh, K., Kilpatrick, R. D., McAllister, C. J., Greenland, S., & Kopple, J. D. (2005) · Hypertension · doi:10.1161/01.hyp.0000154895.18269.67 · Cited by 226
Self-citationBlood Pressure and Mortality in U.S. Veterans With Chronic Kidney Disease: A Cohort Study
Kovesdy, C. P., Bleyer, A. J., Molnar, M. Z., Ma, J. Z., Sim, J. J., Cushman, W. C., Quarles, L. D., & Kalantar-Zadeh, K. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-4-201308200-00004 · Cited by 213
Self-citationTaler, S. J., Agarwal, R., Bakris, G. L., Flynn, J. T., Nilsson, P. M., Rahman, M., Sanders, P. W., Textor, S. C., Weir, M. R., & Townsend, R. R. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.03.018 · Cited by 201
Self-citationCourse of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.
Nosadini, R., Velussi, M., Brocco, E., Bruseghin, M., Abaterusso, C., Saller, A., Vestra, M. D., Carraro, A., Bortoloso, E., Sambataro, M. P., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.3.476 · Cited by 201
Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes
Ricks, J., Molnar, M. Z., Kovesdy, C. P., Shah, A. P., Nissenson, A. R., Williams, M. E., & Kalantar‐Zadeh, K. (2012) · Diabetes · doi:10.2337/db11-1015 · Cited by 193
Self-citationBone mineral density in subjects using central nervous system-active medications
Kinjo, M., Setoguchi, S., Schneeweiss, S., & Solomon, D. H. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.07.033 · Cited by 191
Deacon, C. F., Mannucci, E., & Ahrén, B. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01603.x · Cited by 190
Effects of Fibrates in Kidney Disease
Jun, M., Zhu, B., Tonelli, M., Jardine, M. J., Patel, A., Neal, B., Liyanage, T., Keech, A., Cass, A., & Perkovic, V. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.049 · Cited by 189 · cited 1×
“73 m(2)) population, further studies are warranted before widespread use of these agents in CKD is recommended (36).”
Qaseem, A., HOPKINS, R. H., Sweet, D. E., Starkey, M., & Shekelle, P. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-12-201312170-00726 · Cited by 189
Microalbuminuria as a Risk Predictor in Diabetes: The Continuing Saga
Bakris, G. L., & Molitch, M. E. (2014) · Diabetes Care · doi:10.2337/dc13-1870 · Cited by 186
Self-citationMicrovascular disease: what does the UKPDS tell us about diabetic nephropathy?
Bilous, R. W. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02496.x · Cited by 178
Self-citationMultidisciplinary Team Care May Slow the Rate of Decline in Renal Function
Bayliss, E. A., Bhardwaja, B., Ross, C. A., Beck, A. L., & Lanese, D. M. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06610810 · Cited by 177
Effects of Lowering LDL Cholesterol on Progression of Kidney Disease
Haynes, R., Lewis, D., Emberson, J., Reith, C. A., Agodoa, L. Y. C., Cass, A., Craig, J. C., de Zeeuw, D., Feldt‐Rasmussen, B., Fellström, B., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013090965 · Cited by 175
Patient-Centered Medical Home and Diabetes
Bojadzievski, T., & Gabbay, R. A. (2011) · Diabetes Care · doi:10.2337/dc10-1671 · Cited by 175
Low-protein diet for diabetic nephropathy: a meta-analysis of randomized controlled trials
Pan, Y., Guo, L. L., & Jin, H. M. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.3.660 · Cited by 174
Wheeler, D. C., & Becker, G. J. (2013) · Kidney International · doi:10.1038/ki.2012.425 · Cited by 169
Red Blood Cell Survival in Long-term Dialysis Patients
Vos, F. E., Schollum, J. B. W., Coulter, C. V., Doyle, T. C. A., Duffull, S. B., & Walker, R. J. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.03.031 · Cited by 160
Updates on the Management of Diabetes in Dialysis Patients
Rhee, C. M., Leung, A. M., Kovesdy, C. P., Lynch, K. E., Brent, G. A., & Kalantar‐Zadeh, K. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12198 · Cited by 158
Self-citationBurrows, N. R., Li, Y., & Geiss, L. S. (2009) · Diabetes Care · doi:10.2337/dc09-0343 · Cited by 158
Sodium-Glucose Co-Transport Inhibitors
Neumiller, J. J., White, J. R., & Campbell, R. K. (2010) · Drugs · doi:10.2165/11318680-000000000-00000 · Cited by 156
Self-citationEffects of Structured Versus Usual Care on Renal Endpoint in Type 2 Diabetes: The SURE Study
Chan, J. C. N., So, W., Yeung, C., Ko, G. T. C., Lau, I. T., Tsang, M.-W., Lau, K.-P., Siu, S.-C., Li, J. K., Yeung, M. W., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1908 · Cited by 146
Serum homocysteine level and protein intake are related to risk of microalbuminuria: The Hoorn Study
Hoogeveen, E. K., Kostense, P. J., Jager, A., Heine, R. J., Jakobs, C., Bouter, L. M., Donker, A. J. M., & Stehouwer, C. D. A. (1998) · Kidney International · doi:10.1038/sj.ki.4495353 · Cited by 146
Glycemic Control and Survival in Peritoneal Dialysis Patients with Diabetes Mellitus
Duong, U., Mehrotra, R., Molnar, M. Z., Noori, N., Kovesdy, C. P., Nissenson, A. R., & Kalantar‐Zadeh, K. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08921010 · Cited by 145
Self-citationThe pharmacokinetics of pioglitazone in patients with impaired renal function
Budde, K., Neumayer, H., Fritsche, L., Sułowicz, W., Stompór, T. P., & Eckland, D. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01785.x · Cited by 142
Physical Activity and Rapid Decline in Kidney Function Among Older Adults
Robinson‐Cohen, C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.438 · Cited by 142
Association between LDL-C and Risk of Myocardial Infarction in CKD
Tonelli, M. A., Muntner, P., Lloyd, A. M., Manns, B., Klarenbach, S. W., Pannu, N., James, M. T., & Hemmelgarn, B. R. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012080870 · Cited by 142
Rachmani, R., Slavachevski, I., Levi, Z., Zadok, B.-S., Kedar, Y., & Ravid, M. (2002) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(02)00131-0 · Cited by 134
Glycated Albumin and Risk of Death and Hospitalizations in Diabetic Dialysis Patients
Freedman, B. I., Andries, L., Shihabi, Z. K., Rocco, M. V., Byers, J. R., Cardona, C. Y., Pickard, M. A., Henderson, D. L., Sadler, M. V., Courchene, L. M., et al. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11491210 · Cited by 134
Nakao, T., Matsumoto, H., OKADA, T., Han, M., Hidaka, H., Yoshino, M., Shino, T., Yamada, C., & Nagaoka, Y. (1998) · Internal Medicine · doi:10.2169/internalmedicine.37.826 · Cited by 132
Blood Pressure Components and End-stage Renal Disease in Persons With Chronic Kidney Disease
Peralta, C. A., Norris, K. C., Li, S., Chang, T. I., Tamura, M. K., Jolly, S. E., Bakris, G. L., McCullough, P. A., Shlipak, M. G., & for the KEEP Investigators (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.619 · Cited by 131
Self-citationManagement of drugs affecting blood glucose in diabetic patients with renal failure.
Charpentier, G., Riveline, J. P., & Varroud-Vial, M. (2000) · PubMed · Cited by 131
Hasslacher, C., & for the Multinational Repaglinide Renal Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.3.886 · Cited by 117
Dullaart, R. P. F., Beusekamp, B. J., Meijer, S., van Doormaal, J. J., & Sluiter, W. J. (1993) · Diabetes Care · doi:10.2337/diacare.16.2.483 · Cited by 114
Reverse Epidemiology: A Spurious Hypothesis or a Hardcore Reality?
Kalantar‐Zadeh, K., Kilpatrick, R. D., Kuwae, N., & Wu, D. Y. (2004) · Blood Purification · doi:10.1159/000082012 · Cited by 113
Self-citationNational Kidney Disease Education Program.
Hostetter, T. H., & Lising, M. (2002) · PubMed · Cited by 112
Hypoglycemic Activity of Glyburide (Glibenclamide) Metabolites in Humans
Rydberg, T., Jönsson, A., Røder, M. E., & Melander, A. (1994) · Diabetes Care · doi:10.2337/diacare.17.9.1026 · Cited by 111
Calcineurin Inhibition and New-Onset Diabetes Mellitus After Transplantation
Chakkera, H. A., & Mandarino, L. J. (2012) · Transplantation · doi:10.1097/tp.0b013e31826e592e · Cited by 109
Effect of Fenofibrate on Kidney Function: A 6-Week Randomized Crossover Trial in Healthy People
Ansquer, J.-C., Dalton, R. N., Caussé, E., Crimet, D., Le Malicot, K., & Foucher, C. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.01.014 · Cited by 107
Effects of polyunsaturated fatty acid consumption in diabetic nephropathy
Shapiro, H., Theilla, M., Attal-Singer, J., & Singer, P. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.156 · Cited by 105
Hemoglobin A1c Levels and Mortality in the Diabetic Hemodialysis Population
Ramirez, S. P. B., McCullough, K. P., Thumma, J. R., Nelson, R. G., Morgenstern, H., Gillespie, B. W., Inaba, M., Jacobson, S. H., Vanholder, R. C., Pisoni, R. L., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0573 · Cited by 105
Marcovecchio, M. L., Woodside, J., Jones, T. W., Daneman, D., Neil, A., Prevost, A. T., Dalton, R. N., Deanfield, J. E., Dunger, D. B., & on behalf of the AdDIT Investigators (2013) · Diabetes Care · doi:10.2337/dc13-1634 · Cited by 101
Pijls, L., de Vries, H., EIJK, J. V., & Donker, A. J. M. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601474 · Cited by 99
Pharmacokinetics of Oral Antihyperglycaemic Agents in Patients with Renal Insufficiency
Harrower, A. D. B. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631020-00003 · Cited by 97
Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005
Rossing, P. R. (2005) · Diabetologia · doi:10.1007/s00125-005-0077-3 · Cited by 94
Severe dietary protein restriction in overt diabetic nephropathy: Benefits or risks?
Meloni, C., Morosetti, M., SURACI, C., Pennafina, M. G., Tozzo, C., TACCONE-GALLUCCI, M., & Casciani, C. U. (2002) · Journal of Renal Nutrition · doi:10.1053/jren.2002.31762 · Cited by 94
Wrone, E. M., Carnethon, M. R., Palaniappan, L. P., & Fortmann, S. P. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50119 · Cited by 91
Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease
Scheen, A. J. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.777428 · Cited by 91
Patient Self-Management Support Programs
Pearson, M. L., Mattke, S., Shaw, R., Ridgely, M. S., & Wiseman, S. H. (2007) · Cited by 90
Molnar, M. Z., Kovesdy, C. P., Bunnapradist, S., Streja, E., Mehrotra, R., Krishnan, M., Nissenson, A. R., & Kalantar‐Zadeh, K. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03480.x · Cited by 89
Self-citationGlycemic Control in Diabetic CKD Patients: Where Do We Stand?
Kovesdy, C. P., Sharma, K., & Kalantar‐Zadeh, K. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.04.011 · Cited by 88
Self-citationGiorda, C. B., Nada, E., & Tartaglino, B. (2014) · Endocrine · doi:10.1007/s12020-014-0179-0 · Cited by 87
Kalantar‐Zadeh, K., Derose, S. F., Nicholas, S., Benner, D. A., Sharma, K., & Kovesdy, C. P. (2009) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2008.11.012 · Cited by 85
Self-citationDussol, B., Iovanna, C., Raccah, D., Darmon, P., Morange, S., Vague, P., Vialettes, B., Oliver, C., Loundoun, A., & Berland, Y. (2005) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2005.07.003 · Cited by 84
Círillo, M., Lombardi, C., Chiricone, D., Santo, N. G. D., Zanchetti, A., & Bilancio, G. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu056 · Cited by 83
Mild Renal Impairment and the Efficacy and Safety of Liraglutide
Davidson, J. A., Brett, J., Falahati, A., & Scott, D. (2010) · Endocrine Practice · doi:10.4158/ep10215.or · Cited by 82
Rossi, M. C., Nicolucci, A., Arcangeli, A., Cimino, A., Bigontina, G. D., Giorda, C. B., Meloncelli, I., Pellegrini, F., Valentini, U., Vespasiani, G., et al. (2008) · Diabetes Care · doi:10.2337/dc08-0469 · Cited by 81
Epidemiology of Dialysis Patients and Heart Failure Patients
Kalantar‐Zadeh, K., Abbott, K. C., Kronenberg, F., Anker, S. D., Horwich, T. B., & Fonarow, G. C. (2006) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2005.09.005 · Cited by 80
Self-citationAssessing glycemic control in patients with diabetes and end-stage renal failure
Ansari, A., Thomas, S., & Goldsmith, D. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50114 · Cited by 80
Raal, F. J., Kalk, W., Lawson, M., Esser, J., Buys, R., Fourie, R. L., & Panz, V. (1994) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/60.4.579 · Cited by 80
Can New-Onset Diabetes After Kidney Transplant Be Prevented?
Chakkera, H. A., Weil, E. J., Pham, P. T., Pomeroy, J. J., & Knowler, W. C. (2013) · Diabetes Care · doi:10.2337/dc12-2067 · Cited by 80
Pharmacokinetics of glipizide in man: Influence of renal insufficiency
Balant, L., Zahnd, G. R., Gorgia, A., Schwarz, R., & Fabre, J. (1973) · Diabetologia · doi:10.1007/bf01218443 · Cited by 79
Pharmacokinetics of Rosiglitazone in Patients with Varying Degrees of Renal Insufficiency
Chapelsky, M. C., Culkin, K. T., Miller, A. K., Sack, M. R., Blum, R. A., & Freed, M. I. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270002250602 · Cited by 78
Glycemic Control in Diabetic Dialysis Patients and the Burnt-Out Diabetes Phenomenon
Park, J., Lertdumrongluk, P., Molnar, M. Z., Kovesdy, C. P., & Kalantar‐Zadeh, K. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0286-3 · Cited by 73
Self-citationBachmann, L. M., Nilsson, G., Bruns, D. E., McQueen, M. J., Lieske, J. C., Zakowski, J. J., & Miller, W. G. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.210302 · Cited by 68
Hansen, H. P., Christensen, P. K., Tauber-Lassen, E., Klausen, A., Jensen, B. R., & Parving, H. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00274.x · Cited by 67
Leung, W. Y. S., So, W., Tong, P. C. Y., Chan, N. N., & Chan, J. C. N. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.07.050 · Cited by 66
Severe Hypoglycemia in Type I Diabetic Patients With Impaired Kidney Function
Mühlhauser, I., Tóth, G., Sawicki, P. T., & Berger, M. (1991) · Diabetes Care · doi:10.2337/diacare.14.4.344 · Cited by 64
Causes and consequences of the reverse epidemiology of body mass index in dialysis patients
Kalantar‐Zadeh, K. (2005) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2004.09.020 · Cited by 61
Self-citationSaydah, S., Pavkov, M. E., Zhang, C., Lacher, D. A., Eberhardt, M. S., Burrows, N. R., Narva, A. S., Eggers, P. W., & Williams, D. E. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.195644 · Cited by 61
Self-citationEvans, M., Bain, S. C., Hogan, S., & Bilous, R. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr696 · Cited by 58
Self-citationKim, W. J., Park, C., Lee, K., Park, S. E., Rhee, E., Lee, W., Oh, K. W., & Park, S. W. (2011) · Diabetes Care · doi:10.2337/dc11-1462 · Cited by 56
Pharmacokinetics of Rosiglitazone in Patients with End-Stage Renal Disease
Culkin, K. T., Zussman, B. D., Miller, A. K., & Freed, M. I. (2002) · Journal of International Medical Research · doi:10.1177/147323000203000405 · Cited by 56
Microvascular Complications in Adolescents with Type 1 Diabetes Mellitus
DEMİREL, F., Derya, T., Kara, Ö., & Esen, İ. (2013) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.994 · Cited by 53
Pendergrass, M. L., Fenton, C. L., Haffner, S. M., & Chen, W. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01567.x · Cited by 53
Lee, B. J., & Forbes, K. (2009) · BMJ · doi:10.1136/bmj.b2395 · Cited by 52
Schumock, G. T., Andress, D. L., Marx, S. E., Sterz, R., Joyce, A. T., & Kalantar‐Zadeh, K. (2009) · Nephron Clinical Practice · doi:10.1159/000228076 · Cited by 50
Self-citationHypoglycemia due to nateglinide administration in diabetic patient with chronic renal failure
Nagai, T., Imamura, M., Iizuka, K., & Mori, M. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00242-5 · Cited by 49
Lee, C. C., Sharp, S. J., Wexler, D. J., & Adler, A. (2010) · Diabetes Care · doi:10.2337/dc09-2245 · Cited by 48
Kalantar‐Zadeh, K., Uppot, R. N., & Lewandrowski, K. B. (2013) · New England Journal of Medicine · doi:10.1056/nejmcpc1208154 · Cited by 48
Self-citationKalantar‐Zadeh, K. (2012) · Diabetes Care · doi:10.2337/dc12-0483 · Cited by 44
Self-citationKalantar‐Zadeh, K. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00360.x · Cited by 43
Self-citationFriedrich, C., Emser, A., Woerle, H., & Graefe‐Mody, U. (2013) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31826232dc · Cited by 41
The Safety of Metformin in Heart Failure
Roberts, F., & Ryan, G. J. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h523 · Cited by 34
Sarno, G., Mehta, R. J., Guardado‐Mendoza, R., Jiménez-Ceja, L. M., Rosa, P. D., & Muscogiuri, G. (2012) · Current Diabetes Reviews · doi:10.2174/157339913804143234 · Cited by 34
Sarno, G., Mehta, R. J., Guardado‐Mendoza, R., Jiménez-Ceja, L. M., Rosa, P. D., & Muscogiuri, G. (2012) · Current Diabetes Reviews · doi:10.2174/1573399811309010078 · Cited by 31
Lee, B., Turley, M., Meng, D., Zhou, Y., Garrido, T., Lau, A. H., & Radler, L. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-252 · Cited by 29
Tuttle, K. R., Heilmann, C. R., Hoogwerf, B. J., Brown, C. J., & Anderson, P. W. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.03.026 · Cited by 28
Self-citationChen, P., Huang, Y., Kao, Y., & Chen, J.-Y. (2010) · Journal of Nursing Research · doi:10.1097/jnr.0b013e3181dda726 · Cited by 27
Pawaskar, M. D., Tuttle, K. R., Li, Q., Best, J. H., & Anderson, P. W. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028013520597 · Cited by 26
Self-citationAbe, M., Okada, K., Maruyama, T., Maruyama, N., Soma, M., & Matsumoto, K. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.495119 · Cited by 25
Using Hemoglobin A1c to Derive Mean Blood Glucose in Peritoneal Dialysis Patients
Hoshino, J., Mehrotra, R., Rhee, C. M., Yamagata, K., Ubara, Y., Takaichi, K., Kovesdy, C. P., Molnar, M. Z., & Kalantar‐Zadeh, K. (2013) · American Journal of Nephrology · doi:10.1159/000349929 · Cited by 24
Self-citationObesity Paradox as a Component of Reverse Epidemiology in Heart Failure
Kalantar‐Zadeh, K., Anker, S. D., Coats, A. J. S., Horwich, T. B., & Fonarow, G. C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.15.1797-a · Cited by 24
Self-citationShojania, K. G., Ranji, S. R., McDonald, K. M., Grimshaw, J. M., Sundaram, V., Rushakoff, R. J., & Owens, D. K. (2006) · JAMA · doi:10.1001/jama.296.4.427 · Cited by 20
Skeletal Toxicity of Thiazolidinediones
Grey, A. B. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-7-200804010-00020 · Cited by 18
The Future of Interventional Management of Hypertension: Threats and Opportunities
Briasoulis, Α., & Bakris, G. (2014) · Current Vascular Pharmacology · doi:10.2174/15701611113119990137 · Cited by 13
Self-citationGoldstein-Fuchs, D. J., & LaPierre, A. F. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-4617-0.00054-6 · Cited by 9
Obesity paradox as a component of reverse epidemiology in heart failure [6] (multiple letters)
Kalantar‐Zadeh, K., Anker, S. D., Coats, A. J. S., Horwich, T. B., Fonarow, G. C., Curtis, J. P., Wang, Y., & Krumholz, H. M. (2005) · eScholarship (California Digital Library) · Cited by 7
Self-citationBMJ Publishing Group Ltd (2014) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2014.4.0244 · Cited by 7
RAS blockade, hyperkalemia and AKI—look and you will find
Toto, R. D. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.62 · Cited by 5
Flagged first, then by citations
2 of the 193 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Diabetic Kidney Disease: Challenges, Progress, and Possibilities
Alicic, R. Z., Rooney, M. T., & Tuttle, K. R. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11491116 · Cited by 2,898
Self-citationNutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014
Afkarian, M., Zelnick, L. R., Hall, Y. N., Heagerty, P. J., Tuttle, K., Weiss, N. S., & de Boer, I. H. (2016) · JAMA · doi:10.1001/jama.2016.10924 · Cited by 1,026
Self-citationGlomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment
Tonneijck, L., Muskiet, M. H. A., Smits, M. M., van Bommel, E. J., Heerspink, H. J. L., van Raalte, D. H., & Joles, J. A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060666 · Cited by 887
Differentiation of diabetes by pathophysiology, natural history, and prognosis
Skyler, J. S., Bakris, G. L., Bonifacio, E., Darsow, T., Eckel, R. H., Groop, L., Groop, P.-H., Handelsman, Y., Insel, R. A., Mathieu, C., et al. (2017) · Diabetes · doi:10.2337/db16-0806 · Cited by 823
Self-citation
Metadata
- Authors
- Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., Neumiller, J. J., Patel, U. D., Ratner, R. E., Whaley-Connell, A. T., & Molitch, M. E.
- Affiliations
- University of Washington (US)
- National Kidney Foundation (US)
- Newcastle University (GB)
- American Diabetes Association (US)
- Division of Nephrology, University of Washington, Seattle, WA
- Sierra Nevada Nephrology Consultants, Reno, NV
- School of Medicine, University of California, Irvine, Irvine, CA
- National Institutes of Health (US)
- Cleveland Clinic (US)
- Washington State University Spokane (US)
- Duke University (US)
- Harry S. Truman Memorial Veterans Hospital, Columbia, MO, and Department of Internal Medicine, Division of Nephrology and Hypertension, University of Missouri School of Medicine, Columbia, MO
- Northwestern University (US)
- Corresponding author
- Chiang, Jane L.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-09-10
- Volume
- 37
- Issue
- 10
- Pages
- 2864-2883
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC4170131
- OpenAlex
- W2072070798
- Semantic Scholar
- 0c6864a569d8918ea51eda33aae122cff819ac65
- Cited by
- 1,153
- References
- 193
- Citations by year
- 2026: 90 · 2025: 104 · 2024: 107 · 2023: 131 · 2022: 128 · 2021: 118 · 2020: 130 · 2019: 87 · 2018: 87 · 2017: 72 · 2016: 65 · 2015: 27 · 2014: 6
- FWCI
- 44.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- AstraZeneca
- Sanofi
- Gilead Sciences
- Halozyme
- Luitpold Pharmaceuticals
- Angion
- Novo Nordisk
- CSL Limited
- National Institutes of Health (UL1TR000430)
- Relypsa
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Advancing Translational Sciences
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Keywords
- diabetic nephropathy, end-stage renal disease, type 2 diabetes, chronic kidney disease, cardiovascular disease, dyslipidemia, hypertension, renin-angiotensin-aldosterone system blockade, mineralocorticoid receptor antagonists, glycemic control, hypoglycemia, pharmacotherapy, pediatric diabetes, multidisciplinary care, patient-centered medical home, health care delivery
- MeSH terms
- Adolescent, Aged, Antihypertensive Agents, Blood Glucose, Cardiovascular Diseases, Child, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Humans, Kidney Function Tests, Middle Aged, Incidence, Prevalence, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
